30 participants
An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Primary Focal Segmental Glomerulosclerosis
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-26
- Start Date:
- 2026-05-28
- Completion:
- 2027-11-30
Conditions
- Focal Segmental Glomerulosclerosis
Interventions
- DRUG
No Results Yet